On December 3, 2024, the Federal Court of Appeal (FCA) set aside the order of the Patented Medicine Prices Review Board (PMPRB or Board) that had required Galderma to continue to provide information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results